We are live on !
Find out more
Candriam SCA Portfolio holdings
AUM
$22.2B
Turnover
11.97%
1-Year Est. Return
58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
(+15%)
Cap. Flow
-$534M
Cap. Flow % of AUM
Cap. Flow %
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50
Avg Time Held
5.8
years
Top 10 Avg Time Held
3.7
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$110M |
| 2 |
Entegris
ENTG
|
+$53.1M |
| 3 |
Hilton Worldwide
HLT
|
+$45.7M |
| 4 |
Intuitive Surgical
ISRG
|
+$44.3M |
| 5 |
Western Digital
WDC
|
+$41.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$68.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.3M |
| 3 |
Microsoft
MSFT
|
+$64.1M |
| 4 |
Gilead Sciences
GILD
|
+$63.1M |
| 5 |
ON Semiconductor
ON
|
+$62.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.31% |
| 2 | Healthcare | 24.36% |
| 3 | Financials | 9.42% |
| 4 | Communication Services | 7.08% |
| 5 | Consumer Discretionary | 6.73% |
Similar funds
DCP
Candriam SCA's Q2 2026 Portfolio in Review
As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
- Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
- Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
- Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
- Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
- Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
- Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
- Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.